Quick facts

Founding Year Team Members Headquarters

2013

Niel, Belgium
CEO Pipeline Other locations

Steven Powell          

Learn More

7 preclinical projects      

1 clinical project

detailed pipeline

Ghent,
Belgium

New York,
USA

Sheung Wan,
Hong Kong

Therapeutic
Areas
Capitalization Founding
Investors

          Oncology        

Infectious
Diseases

EUR 63 million
in equity investment    

Series A financing
of EUR 24 million
in 2016

Series B financing
of EUR 39 million
mid-2020.

Vrije Universiteit
Brussel

Progress Pharma

Shareholders

Galileilaan 19, 2845 Niel, Belgium

Our Address

Our Mailbox

+32 3 369 17 40

Our Phone

© 2021 eTheRNA | Studio Hanswijk